Subtopic Deep Dive
Probiotics for Infantile Colic Treatment
Research Guide
What is Probiotics for Infantile Colic Treatment?
Probiotics for Infantile Colic Treatment evaluates the efficacy of Lactobacillus reuteri strains, particularly DSM 17938 and ATCC 55730, in reducing crying time in breastfed infants through randomized controlled trials and microbiota analysis.
Multiple RCTs demonstrate Lactobacillus reuteri DSM 17938 reduces colic symptoms in exclusively breastfed infants (Savino et al., 2010, 327 citations; Sung et al., 2014, 243 citations). Studies identify distinct gut microbiota signatures in colicky infants, with lower biodiversity compared to controls (de Weerth et al., 2013, 275 citations). Meta-analyses confirm strain-specific benefits and safety, supporting guideline updates for first-line management.
Why It Matters
Probiotics like Lactobacillus reuteri DSM 17938 shorten crying duration by over 50% in RCTs, reducing parental stress and healthcare visits (Savino et al., 2010; Sung et al., 2014). Microbiota modulation addresses colic's gut dysbiosis origin, influencing Rome IV criteria for functional GI disorders (Zeevenhooven et al., 2017). Evidence drives pediatric guidelines, with safety profiles favoring live strains over heat-killed alternatives (Mu et al., 2018; Piqué et al., 2019).
Key Research Challenges
Strain Specificity Variability
Efficacy differs between L. reuteri DSM 17938 and ATCC 55730, with inconsistent results across feeding types (Savino et al., 2007; Savino et al., 2010). Meta-analyses show benefits limited to breastfed infants (Sung et al., 2014). Standardization of strains and dosages remains unresolved.
Microbiota Causality Proof
Colic infants exhibit reduced microbiota diversity, but causation versus correlation is unclear (de Weerth et al., 2013). Probiotics alter composition, yet long-term impacts on immunity are understudied (Grönlund et al., 2000). RCTs link modulation to symptom relief without mechanistic clarity.
Safety in Vulnerable Infants
Live probiotics risk translocation in immunocompromised infants, unlike heat-killed options (Piqué et al., 2019). Trials report no adverse events, but broader safety data lacks (Mu et al., 2018). Dose-response relationships need pediatric-specific profiling.
Essential Papers
Role of Lactobacillus reuteri in Human Health and Diseases
Qinghui Mu, Vincent J. Tavella, Xin Luo · 2018 · Frontiers in Microbiology · 686 citations
<i>Lactobacillus reuteri</i> (<i>L. reuteri</i>) is a well-studied probiotic bacterium that can colonize a large number of mammals. In humans, <i>L. reuteri</i> is found in different body sites, in...
Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview
Núria Piqué, Mercedes Berlanga, David Miñana‐Galbis · 2019 · International Journal of Molecular Sciences · 563 citations
Nowadays, the oral use of probiotics is widespread. However, the safety profile with the use of live probiotics is still a matter of debate. Main risks include: Cases of systemic infections due to ...
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms
Joe Alcock, Carlo C. Maley, Athena Aktipis · 2014 · BioEssays · 435 citations
Microbes in the gastrointestinal tract are under selective pressure to manipulate host eating behavior to increase their fitness, sometimes at the expense of host fitness. Microbes may do this thro...
The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers
Judith Zeevenhooven, Ilan J.N. Koppen, Marc A. Benninga · 2017 · Pediatric Gastroenterology Hepatology & Nutrition · 330 citations
Functional gastrointestinal disorders (FGIDs) are common worldwide and cover a wide range of disorders attributable to the gastrointestinal tract that cannot be explained by structural or biochemic...
<i>Lactobacillus reuteri</i>DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial
Francesco Savino, Lisa Cordisco, Valentina Tarasco et al. · 2010 · PEDIATRICS · 327 citations
OBJECTIVE: To test the efficacy of Lactobacillus reuteri on infantile colic and to evaluate its relationship to the gut microbiota. STUDY DESIGN: Fifty exclusively breastfed colicky infants, diagno...
Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review
Huiying Wang, In‐Seon Lee, Christoph Braun et al. · 2016 · Journal of Neurogastroenterology and Motility · 319 citations
To systematically review the effects of probiotics on central nervous system function in animals and humans, to summarize effective interventions (species of probiotic, dose, duration), and to anal...
<i>Lactobacillus reuteri</i>(American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study
Francesco Savino, Emanuela Pelle, E Palumeri et al. · 2007 · PEDIATRICS · 305 citations
OBJECTIVE. The goal was to test the hypothesis that oral administration of Lactobacillus reuteri in a prospective randomized study would improve symptoms of infantile colic. METHODS. Ninety breastf...
Reading Guide
Foundational Papers
Start with Savino et al. (2010, 327 citations) for DSM 17938 RCT efficacy; Savino et al. (2007, 305 citations) for strain comparison; de Weerth et al. (2013, 275 citations) for colic microbiota signatures establishing dysbiosis link.
Recent Advances
Sung et al. (2014, 243 citations) confirms breastfed benefits in larger RCT; Mu et al. (2018, 686 citations) reviews L. reuteri health roles; Zeevenhooven et al. (2017, 330 citations) updates Rome IV colic criteria.
Core Methods
RCTs use Wessel criteria, 10^8 CFU doses, parental crying logs; microbiota via fecal 16S rRNA sequencing, qPCR for Bifidobacterium/Lactobacillus; GRADE for evidence synthesis (Savino et al., 2010; de Weerth et al., 2013).
How PapersFlow Helps You Research Probiotics for Infantile Colic Treatment
Discover & Search
Research Agent uses searchPapers with 'Lactobacillus reuteri DSM 17938 infantile colic RCT' to retrieve Savino et al. (2010, 327 citations), then citationGraph maps 50+ citing RCTs and meta-analyses like Sung et al. (2014). exaSearch uncovers strain-specific reviews; findSimilarPapers links de Weerth et al. (2013) microbiota studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract crying time reductions from Savino et al. (2010), then verifyResponse with CoVe cross-checks against Sung et al. (2014) for GRADE B evidence grading on breastfed efficacy. runPythonAnalysis meta-analyzes dose-responses via pandas on RCT data tables for statistical verification.
Synthesize & Write
Synthesis Agent detects gaps in formula-fed infant data via contradiction flagging across Savino trials, then Writing Agent uses latexEditText for RCT summary tables, latexSyncCitations for 20+ references, and latexCompile for publication-ready review. exportMermaid visualizes microbiota modulation pathways from de Weerth et al. (2013).
Use Cases
"Extract colic crying time data from Savino RCTs and compute meta-analysis effect size."
Research Agent → searchPapers('Savino reuteri colic') → Analysis Agent → readPaperContent(Savino 2010/2007) → runPythonAnalysis(pandas meta-analysis, forest plot) → researcher gets CSV of pooled OR=0.45 (95% CI).
"Draft LaTeX systematic review on L. reuteri DSM 17938 for colic guidelines."
Synthesis Agent → gap detection(Savino/Sung RCTs) → Writing Agent → latexGenerateFigure(flowchart), latexSyncCitations(15 papers), latexCompile → researcher gets PDF with GRADE tables and bibliography.
"Find GitHub code for infant colic microbiota analysis pipelines."
Research Agent → paperExtractUrls(de Weerth 2013) → Code Discovery → paperFindGithubRepo → githubRepoInspect(16S pipeline) → researcher gets QIIME2 repo with colic signature scripts.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(100+ hits on reuteri colic) → citationGraph → DeepScan(7-step GRADE assessment of Savino RCTs) → structured report with effect sizes. Theorizer generates hypotheses on microbiota-host craving links from Alcock et al. (2014) + de Weerth (2013). Chain-of-Verification ensures no hallucinated mechanisms.
Frequently Asked Questions
What defines probiotics for infantile colic treatment?
RCTs test Lactobacillus reuteri DSM 17938 (5×10^8 CFU/day) efficacy in breastfed colicky infants per modified Wessel criteria, reducing crying >50% versus placebo (Savino et al., 2010).
What are key methods in this subtopic?
Double-blind RCTs compare L. reuteri to simethicone/placebo, measuring crying time via parental diaries; microbiota via 16S sequencing (Savino et al., 2007; de Weerth et al., 2013).
What are the most cited papers?
Savino et al. (2010, 327 citations) RCT on DSM 17938; Savino et al. (2007, 305 citations) ATCC 55730 vs. simethicone; de Weerth et al. (2013, 275 citations) colic microbiota signatures.
What open problems exist?
Strain/dose optimization for formula-fed infants; long-term microbiota/immunity effects; causality of dysbiosis in colic etiology (Sung et al., 2014; Grönlund et al., 2000).
Research Infant Health and Development with AI
PapersFlow provides specialized AI tools for Health Professions researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Probiotics for Infantile Colic Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Health Professions researchers
Part of the Infant Health and Development Research Guide